vs
ENVIRI Corp（NVRI）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
Revvity的季度营收约是ENVIRI Corp的1.4倍（$772.1M vs $555.0M），Revvity净利率更高（12.7% vs -15.2%，领先27.9%），Revvity同比增速更快（5.9% vs -0.8%），Revvity自由现金流更多（$161.8M vs $-10.5M），过去两年Revvity的营收复合增速更高（9.0% vs -3.8%）
Enviri集团是总部位于美国宾夕法尼亚州费城的环保企业，业务覆盖全球30多个国家，员工总数约1.2万人。公司专注为钢铁、铁路、能源等大型工业领域客户解决复杂的环保相关问题，提供针对性的环境治理解决方案。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
NVRI vs RVTY — 直观对比
营收规模更大
RVTY
是对方的1.4倍
$555.0M
营收增速更快
RVTY
高出6.6%
-0.8%
净利率更高
RVTY
高出27.9%
-15.2%
自由现金流更多
RVTY
多$172.3M
$-10.5M
两年增速更快
RVTY
近两年复合增速
-3.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $555.0M | $772.1M |
| 净利润 | $-84.3M | $98.4M |
| 毛利率 | — | — |
| 营业利润率 | -6.4% | 14.5% |
| 净利率 | -15.2% | 12.7% |
| 营收同比 | -0.8% | 5.9% |
| 净利润同比 | 0.7% | 3.9% |
| 每股收益（稀释后） | $-1.04 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NVRIRVTY
| Q4 25 | $555.0M | $772.1M | ||
| Q3 25 | $574.8M | $698.9M | ||
| Q2 25 | $562.3M | $720.3M | ||
| Q1 25 | $548.3M | $664.8M | ||
| Q4 24 | $559.2M | $729.4M | ||
| Q3 24 | $573.6M | $684.0M | ||
| Q2 24 | $610.0M | $691.7M | ||
| Q1 24 | $600.3M | $649.9M |
净利润NVRIRVTY
| Q4 25 | $-84.3M | $98.4M | ||
| Q3 25 | $-22.3M | $46.7M | ||
| Q2 25 | $-47.6M | $53.9M | ||
| Q1 25 | $-13.4M | $42.2M | ||
| Q4 24 | $-84.9M | $94.6M | ||
| Q3 24 | $-13.2M | $94.4M | ||
| Q2 24 | $-13.6M | $55.4M | ||
| Q1 24 | $-18.0M | $26.0M |
毛利率NVRIRVTY
| Q4 25 | — | — | ||
| Q3 25 | — | 53.6% | ||
| Q2 25 | — | 54.5% | ||
| Q1 25 | — | 56.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | — | 55.7% | ||
| Q1 24 | — | 54.6% |
营业利润率NVRIRVTY
| Q4 25 | -6.4% | 14.5% | ||
| Q3 25 | 2.9% | 11.7% | ||
| Q2 25 | -1.3% | 12.6% | ||
| Q1 25 | 5.6% | 10.9% | ||
| Q4 24 | -11.4% | 16.3% | ||
| Q3 24 | 6.5% | 14.3% | ||
| Q2 24 | 5.1% | 12.4% | ||
| Q1 24 | 4.3% | 6.8% |
净利率NVRIRVTY
| Q4 25 | -15.2% | 12.7% | ||
| Q3 25 | -3.9% | 6.7% | ||
| Q2 25 | -8.5% | 7.5% | ||
| Q1 25 | -2.4% | 6.4% | ||
| Q4 24 | -15.2% | 13.0% | ||
| Q3 24 | -2.3% | 13.8% | ||
| Q2 24 | -2.2% | 8.0% | ||
| Q1 24 | -3.0% | 4.0% |
每股收益（稀释后）NVRIRVTY
| Q4 25 | $-1.04 | $0.86 | ||
| Q3 25 | $-0.28 | $0.40 | ||
| Q2 25 | $-0.59 | $0.46 | ||
| Q1 25 | $-0.17 | $0.35 | ||
| Q4 24 | $-1.07 | $0.77 | ||
| Q3 24 | $-0.16 | $0.77 | ||
| Q2 24 | $-0.17 | $0.45 | ||
| Q1 24 | $-0.22 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $103.7M | $919.9M |
| 总债务越低越好 | $1.6B | — |
| 股东权益账面价值 | $255.1M | $7.3B |
| 总资产 | $2.7B | $12.2B |
| 负债/权益比越低杠杆越低 | 6.10× | — |
8季度趋势，按日历期对齐
现金及短期投资NVRIRVTY
| Q4 25 | $103.7M | $919.9M | ||
| Q3 25 | $115.4M | $931.4M | ||
| Q2 25 | $97.8M | $991.8M | ||
| Q1 25 | $102.5M | $1.1B | ||
| Q4 24 | $88.4M | $1.2B | ||
| Q3 24 | $110.2M | $1.2B | ||
| Q2 24 | $104.0M | $2.0B | ||
| Q1 24 | $103.9M | $1.7B |
总债务NVRIRVTY
| Q4 25 | $1.6B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益NVRIRVTY
| Q4 25 | $255.1M | $7.3B | ||
| Q3 25 | $361.1M | $7.4B | ||
| Q2 25 | $376.3M | $7.6B | ||
| Q1 25 | $409.0M | $7.6B | ||
| Q4 24 | $391.5M | $7.7B | ||
| Q3 24 | $484.0M | $7.9B | ||
| Q2 24 | $485.7M | $7.9B | ||
| Q1 24 | $500.9M | $7.8B |
总资产NVRIRVTY
| Q4 25 | $2.7B | $12.2B | ||
| Q3 25 | $2.8B | $12.1B | ||
| Q2 25 | $2.8B | $12.4B | ||
| Q1 25 | $2.7B | $12.4B | ||
| Q4 24 | $2.6B | $12.4B | ||
| Q3 24 | $2.8B | $12.8B | ||
| Q2 24 | $2.8B | $13.4B | ||
| Q1 24 | $2.8B | $13.4B |
负债/权益比NVRIRVTY
| Q4 25 | 6.10× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 3.66× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $38.4M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | $-10.5M | $161.8M |
| 自由现金流率自由现金流/营收 | -1.9% | 21.0% |
| 资本支出强度资本支出/营收 | 8.8% | 2.6% |
| 现金转化率经营现金流/净利润 | — | 1.85× |
| 过去12个月自由现金流最近4个季度 | $-39.9M | $509.4M |
8季度趋势，按日历期对齐
经营现金流NVRIRVTY
| Q4 25 | $38.4M | $182.0M | ||
| Q3 25 | $34.4M | $138.5M | ||
| Q2 25 | $22.0M | $134.3M | ||
| Q1 25 | $6.6M | $128.2M | ||
| Q4 24 | $36.3M | $174.2M | ||
| Q3 24 | $1.4M | $147.9M | ||
| Q2 24 | $39.0M | $158.6M | ||
| Q1 24 | $1.3M | $147.6M |
自由现金流NVRIRVTY
| Q4 25 | $-10.5M | $161.8M | ||
| Q3 25 | $2.7M | $120.0M | ||
| Q2 25 | $-17.1M | $115.5M | ||
| Q1 25 | $-15.0M | $112.2M | ||
| Q4 24 | $1.8M | $149.8M | ||
| Q3 24 | $-40.2M | $125.6M | ||
| Q2 24 | $5.4M | $136.6M | ||
| Q1 24 | $-25.5M | $129.7M |
自由现金流率NVRIRVTY
| Q4 25 | -1.9% | 21.0% | ||
| Q3 25 | 0.5% | 17.2% | ||
| Q2 25 | -3.0% | 16.0% | ||
| Q1 25 | -2.7% | 16.9% | ||
| Q4 24 | 0.3% | 20.5% | ||
| Q3 24 | -7.0% | 18.4% | ||
| Q2 24 | 0.9% | 19.7% | ||
| Q1 24 | -4.3% | 20.0% |
资本支出强度NVRIRVTY
| Q4 25 | 8.8% | 2.6% | ||
| Q3 25 | 5.5% | 2.6% | ||
| Q2 25 | 6.9% | 2.6% | ||
| Q1 25 | 3.9% | 2.4% | ||
| Q4 24 | 6.2% | 3.4% | ||
| Q3 24 | 7.2% | 3.3% | ||
| Q2 24 | 5.5% | 3.2% | ||
| Q1 24 | 4.5% | 2.7% |
现金转化率NVRIRVTY
| Q4 25 | — | 1.85× | ||
| Q3 25 | — | 2.97× | ||
| Q2 25 | — | 2.49× | ||
| Q1 25 | — | 3.03× | ||
| Q4 24 | — | 1.84× | ||
| Q3 24 | — | 1.57× | ||
| Q2 24 | — | 2.87× | ||
| Q1 24 | — | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NVRI
| Products And Services Service Revenue | $500.2M | 90% |
| After Market Parts And Services Safety And Diagnostic Technology | $23.0M | 4% |
| Railway Track Maintenance Equipment | $16.6M | 3% |
| Railway Contracting Services | $15.9M | 3% |
| Aluminum Dross And Scrap Processing Systems | $3.1M | 1% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
